 |
|
|
|
|
|
|
|
|
|
| |
 |
Notices of Meetings
|
|
|
| |
|
Notices of Proposed Actions
|
|
|
| |
|
Notices of Actions
|
|
|
|
|
|
Meeting Notices |
|
|
| |
2002 |
|
|
| |
|
Notice of Meeting for the March 7-8, 2002, Recombinant DNA Advisory Committee (published February 13, 2002)
|
|
| |
2001 |
|
|
| |
|
Notice of Meeting for the September 6-7, 2001, Recombinant DNA Advisory Committee (published August 14, 2002) |
|
|
| |
|
Notice of Meeting for the June 14-15, 2001, Recombinant DNA Advisory Committee (published May 24, 2001) |
|
|
| |
|
Notice of Meeting and Safety Symposium for the March 7-8, 2001, Recombinant DNA Advisory Committee (published February 23, 2001) |
|
|
| |
2000 |
|
|
| |
|
Notice of Meeting and Safety Symposium for the December 13-15, 2000, Recombinant DNA Advisory Committee (published November 30, 2000) |
|
|
| |
|
Notice of Meeting for the September 25-26, 2000, Recombinant DNA Advisory Committee (published August 22, 2000) |
|
|
| |
|
Notice of Meeting for the June 28-29, 2000, Recombinant DNA Advisory Committee (published June 7, 2000) |
|
|
| |
|
Notice of Meeting for the March 8-10, 2000, Recombinant DNA Advisory Committee (published February 18, 2000) |
|
|
| |
|
An additional notice was published regarding an additional agenda item. (published February 18, 2000) |
|
|
| |
1999 |
|
|
| |
|
Amended Notice of Meeting for the December 8-10, 1999, Recombinant DNA Advisory Committee (published December 7, 1999) |
|
|
| |
|
Notice of a Recombinant DNA Advisory Committee Meeting on December 8-10, 1999 (published November 18, 1999) |
|
|
| |
|
Notice of a Recombinant DNA Advisory Committee Meeting on September 2-3, 1999 (published August 11, 1999) |
|
|
| |
|
Notice of a Recombinant DNA Advisory Committee Meeting on June 14, 1999 (published May 28, 1999) |
|
|
| |
|
Notice of a Recombinant DNA Advisory Committee Meeting on March 11-12, 1999 (published February 17, 1999) |
|
|
| |
|
Notice of a Gene Therapy Policy Conference on January 7-8, 1999 (published December 22, 1998) |
|
|
| |
1998 |
|
|
| |
|
Notice of a Recombinant DNA Advisory Committee Meeting on September 24-25, 1998 (published September 1, 1998) |
|
|
| |
|
Notice of a Recombinant DNA Advisory Committee Meeting on June 18-19, 1998 (published May 4, 1998) |
|
|
| |
|
Notice of a Gene Therapy Policy Conference on March 9, 1998 (published February 11, 1998)
The NIH published a Notice of Conference and agenda items to be discussed at the March 9, 1998, Gene Therapy Policy Conference. |
|
|
| |
|
Notice of a Recombinant DNA Advisory Committee Meeting on March 10, 1998 (published February 11, 1998) |
|
|
| |
1997 |
|
|
| |
|
Notice of a Recombinant DNA Advisory Committee Meeting on December 15-16, 1997 (published October 16, 1997) |
|
|
| |
|
Notice of Recombinant DNA Advisory Committee Meeting on September 12, 1997 (published August 20, 1997) |
|
|
| |
|
Notice of Recombinant DNA Advisory Committee meeting on June 12-13, 1997 (published May 22, 1997) |
|
Top of Page |
| |
|
|
|
|
Notices of Proposed Actions |
|
|
| |
2001 |
|
|
| |
|
Notice of Proposed Actions under the NIH Guidelines (published December 11, 2001) |
|
|
| |
|
Notice of Proposed Actions under the NIH Guidelines (published November 19, 2001) |
|
|
| |
|
Notice of Proposed Actions under the NIH Guidelines (published September 7, 2001) |
|
|
| |
|
Notice of Proposed Actions Actions under the NIH Guidelines (published August 24, 2001) |
|
|
| |
|
Notice of Proposed Actions Actions under the NIH Guidelines (published August 13, 2001) |
|
|
| |
2000 |
|
|
| |
|
Notice of Proposed Actions under the NIH Guidelines (published December 12, 2000) |
|
|
| |
1999 |
|
|
| |
|
Notice of Proposed Actions Under the NIH Guidelines (published November 22, 1999)
These Proposed Actions will be discussed at the December 8-10, 1999, Recombinant DNA Advisory Committee meeting. |
|
|
| |
|
Notice of Proposed Actions Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (published August 11, 1999).
These Proposed Actions will be discussed at the Recombinant DNA Advisory Committee on September 2-3, 1999. |
|
|
| |
|
Notice of Proposed Actions Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (published February 17, 1999).
The NIH published for public comment the Proposed Actions for the March 11-12, 1999, Recombinant DNA Advisory Committee meeting. |
|
|
| |
1998 |
|
|
| |
|
Notice of Proposed Actions Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (published February 11, 1998).
The NIH published for public comment the Proposed Actions for the March 10, 1998, Recombinant DNA Advisory Committee meeting. |
|
|
| |
1997 |
|
|
| |
|
Notice of Proposed Actions Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (published October 16, 1997).
The NIH published for public comment the Proposed Actions for the December 15-16, 1997, Recombinant DNA Advisory Committee meeting. Second Notice of Proposed Actions Under the NIH Guidelines (published November 19, 1997). |
|
|
| |
|
Notice of Proposed Actions Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (published August 20, 1997). |
|
|
| |
|
Notice of Proposed Actions Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (published February 14, 1997). |
|
|
| |
1996 |
|
|
| |
|
Notice of Proposed Actions Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (published November 22, 1996).
The NIH published this Proposed Actions to modify NIH's oversight of human gene therapy. |
|
|
| |
|
Notice of Intent to Proposed Amendments to the NIH Guidelines for Research Involving Recombinant DNA Molecules (published July 8, 1996).
The NIH published a Notice of Intent to modify NIH's oversight of gene therapy. |
|
Top of Page |
| |
|
|
|
|
Notices of Actions |
|
|
| |
2002 |
|
|
| |
|
Notice of Actions under the NIH Guidelines (published May 24, 2002) |
|
|
| |
2001 |
|
|
| |
|
Notice of Actions under the NIH Guidelines (published January 5, 2001). |
|
|
| |
|
Notice of Actions to amend the NIH Guidelines to enhance oversight of human gene transfer research by modifying the requirements for the reporting and analysis of serious adverse events in human gene transfer research studies governed by the NIH Guidelines (published November 19, 2001). |
|
|
| |
|
Notice of Actions amending Appendix B-I of the NIH Guidelines to establish criteria for designating strains of E. coli as risk group 1 agents (published December 11, 2001). |
|
|
| |
|
Notice of Actions amending the provisions of the NIH Guidelines relating to the Recombinant DNA Advisory Committee (RAC) by authorizing a minimum of 15 voting members and establishing the charter of the committee as the controlling document for the membership and procedures of the RAC (published December 11, 2001). |
|
|
| |
2000 |
|
|
| |
|
Notice of Actions under the NIH Guidelines (published October 10, 2000). |
|
|
| |
1999 |
|
|
| |
|
Notice of Action Under the NIH Guidelines for Research Involving Recombinant DNA Molecules Regarding Appendix B--Risk Group 1 (RG1) Agents (published May 11, 1999). |
|
|
| |
1998 |
|
|
| |
|
Notice of Action Under the NIH Guidelines for Research Involving Recombinant DNA Molecules Regarding Electronic Submission of Protocols (published May 11, 1998). |
|
|
| |
|
Notice of Action Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (published February 17, 1998). |
|
|
| |
1997 |
|
|
| |
|
Notice of Action Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (published October 31, 1997).
The NIH published this action to increase the usefulness and productivity of public discussion of human gene transfer research. Specifically, the NIH shall: (1) relinquish all approval responsibilities for recombinant DNA experiments involving human gene transfer to the Food and Drug Administration (FDA), which holds statutory authority for such approval; (2) continue NIH registration of human gene transfer protocols; (3) continue RAC discussion of novel human gene transfer experiments without RAC approval of individual protocols; (4) regularly convene Gene Therapy Policy Conferences; (5) enhance public awareness and access to human gene transfer clinical trial information. |
|
|
| |
|
Procedures for Submission of Human Gene Transfer Protocols
The Procedures for submission of human gene transfer protocols will continue to be according to the NIH Guidelines, Appendix M, The Points to Consider in the Design and Submission of Protocols for the Transfer of Recombinant DNA Molecules into the Genome of One or More Human Subjects (Points to Consider). |
|
|
| |
|
Notice of Environmental Assessment and Finding of No Significant Impact (published November 4, 1997). |
|
|
| |
|
Notice of Action Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (published October 14, 1997).
The NIH published this action to amend Appendix B, Appendix B-III-D, Risk Group 3--Viruses and Prions and Appendix B-IV-D, Risk Group 4--Viral Agents. |
|
|
| |
|
Notice of Action Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (published October 29, 1997). The NIH published this action to amend Appendix M, Submission Requirements. |
|
|
| |
|
Notice of Action Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (published January 31, 1997).
The NIH published this action to reduce the membership of the Recombinant DNA Advisory Committee from 25 to 15 members. |
|
|
| |
1996 |
|
|
| |
|
Notice of Action Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (published March 12, 1996).
This Notice of Action addresses Amendments to Section IV and Appendix M of the NIH Guidelines Regarding Semiannual/Annual Data Reporting |
|
|
| |
|
Notice of Action Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (published January 19, 1996).
This Notice of Action addresses Amendments to Sections II, III, IV, V, Appendices B, C, H, and Q of the NIH Guidelines Regarding Updating the Classification of Microorganisms |
|
|
| |
1995 |
|
|
| |
|
Notice of Action Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (published April 27, 1995).
This Notice of action addresses nine items: 1) Amendments to Section I, Scope of the NIH Guidelines, 2) Amendments to Section III, Experiments Covered by the NIH Guidelines, 3) Amendments to Section IV, Roles and Responsibilities, 4) Amendments to Section V, Footnotes and References of Section I through IV, 5) Amendments to Appendix C, Exemptions under Section III-E-6, 6) Amendments to Appendix F, Containment Conditions for Cloning of Genes Coding for the Biosynthesis of Molecules Toxic for Vertebrates, 7) Amendments to Appendix G, Physical Containment, 8) Amendments to Appendix I, Biological Containment, and 9) Amendments to Appendix M, The Points to Consider in the Design and Submission of Protocols for the Transfer of Recombinant DNA Molecules into the Genome of One or More Human Subjects |
|
|
| |
1994 |
|
|
| |
|
Notice of Action Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (published August 5, 1994)
This Notice of Action addresses three items: 1) Amendment to Appendix M-I-D of the NIH Guidelines Regarding Informed Consent for Human Gene Transfer Protocols, 2) Amendment to Appendix M-VI of the NIH Guidelines Regarding Procedures to be Followed for Expedited Review of Single Patient Human Gene Transfer Experiments, and 3) Deletion of Appendix L of the NIH Guidelines Regarding Release into the Environment. |
|
|
| |
|
Notice of Action Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (published July 5, 1994)
This Notice of Action addresses four separate Actions: 1) Amendment to Sections II, III-C, III-D, V, Appendices C-I, and G and Addition of Appendix P, Physical and Biological Containment for Recombinant DNA Research Involving Plants, and Appendix Q, Physical and Biological Containment for Recombinant DNA Research Involving Animals of the NIH Guidelines, 2) Amendment to Sections I-C-1-b-(2) and Deletion of Section III-A-2 of the NIH Guidelines Regarding Deliberate Release, 3) Amendments to Sections I, III, IV, and V, and Appendix M of the NIH Guidelines Regarding NIH/ORDA Review and Approval of Certain Categories of Human Gene Transfer Experiments That Qualify for the Accelerated Review Process, and 4) Amendments to Section V-U of the NIH Guidelines Regarding Recombinant DNA Vaccines. |
|
Top of Page |
| |
